Diagnostics & Research
The Diagnostics & Research industry has a total of 48 stocks, with a combined market cap of $678.09 billion, total revenue of $168.84 billion and a weighted average PE ratio of 39.04.
Market Cap
678.09B
Revenue
168.84B
Profits
17.37B
PE Ratio
39.04
Profit Margin
10.29%
Dividend Yield
0.24%
48 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 182.98B | 0.36% | 309,419 | 44.56B |
| 2 | DHR | Danaher Corporation | 133.08B | 0.56% | 811,233 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 46.34B | 1.08% | 95,651 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 32.11B | 0.57% | 390,159 | 7.07B |
| 5 | WAT | Waters Corporation | 29.93B | 0.92% | 200,296 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 28.69B | 2.06% | 208,484 | 16.31B |
| 7 | NTRA | Natera, Inc. | 27.38B | -0.69% | 207,828 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.77B | 0.18% | 15,230 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 22.34B | 1.91% | 115,644 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.81B | 0.90% | 100,038 | 11.04B |
| 11 | EXAS | Exact Sciences Corporation | 20.03B | 0.03% | - | 3.25B |
| 12 | ILMN | Illumina, Inc. | 19.27B | -0.15% | 217,653 | 4.34B |
| 13 | MEDP | Medpace Holdings, Inc. | 13.40B | 1.11% | 33,948 | 2.53B |
| 14 | GH | Guardant Health, Inc. | 11.60B | 2.15% | 394,138 | 982.02M |
| 15 | RVTY | Revvity, Inc. | 9.88B | 0.56% | 98,830 | 2.86B |
| 16 | QGEN | Qiagen N.V. | 8.82B | 0.10% | 385,235 | 2.09B |
| 17 | CRL | Charles River Laboratories International, Inc. | 8.20B | 0.36% | 167,842 | 4.02B |
| 18 | ICLR | ICON Public Limited Company | 7.76B | 1.63% | 233,368 | 8.10B |
| 19 | RDNT | RadNet, Inc. | 4.68B | -0.68% | 127,013 | 2.04B |
| 20 | SHC | Sotera Health Company | 3.89B | -0.22% | 223,279 | 1.16B |
| 21 | BLLN | BillionToOne, Inc. | 3.48B | -1.64% | 62,123 | 305.11M |
| 22 | TWST | Twist Bioscience Corporation | 2.93B | -1.81% | 242,434 | 391.56M |
| 23 | VCYT | Veracyte, Inc. | 2.60B | -0.03% | 150,029 | 517.15M |
| 24 | GRAL | GRAIL, Inc. | 2.12B | -1.01% | 168,012 | 147.17M |
| 25 | WGS | GeneDx Holdings Corp. | 1.84B | -6.08% | 395,405 | 427.54M |
| 26 | NEO | NeoGenomics, Inc. | 1.01B | - | 277,621 | 727.33M |
| 27 | CDNA | CareDx, Inc. | 917.80M | -0.88% | 133,935 | 379.81M |
| 28 | OPK | OPKO Health, Inc. | 902.05M | -1.26% | 503,203 | 606.88M |
| 29 | PSNL | Personalis, Inc. | 791.54M | -1.75% | 498,854 | 69.65M |
| 30 | CSTL | Castle Biosciences, Inc. | 760.23M | 1.19% | 82,844 | 344.23M |
| 31 | FLGT | Fulgent Genetics, Inc. | 516.24M | -0.84% | 149,600 | 322.67M |
| 32 | BNR | Burning Rock Biotech Limited | 487.54M | -9.76% | 111,337 | 77.14M |
| 33 | MYGN | Myriad Genetics, Inc. | 433.88M | -0.85% | 273,872 | 824.50M |
| 34 | PRE | Prenetics Global Limited | 356.59M | -1.72% | 94,198 | 92.39M |
| 35 | BDSX | Biodesix, Inc. | 148.86M | -0.33% | 23,794 | 88.50M |
| 36 | MDXH | MDxHealth SA | 139.09M | -1.75% | 32,703 | 107.88M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 124.40M | 4.83% | 41,382 | 4.40M |
| 38 | FONR | FONAR Corporation | 121.61M | -0.22% | 8,397 | 106.03M |
| 39 | XGN | Exagen Inc. | 68.07M | -1.74% | 33,911 | 66.58M |
| 40 | PRPO | Precipio, Inc. | 48.36M | 1.32% | 42,504 | 22.80M |
| 41 | BIAF | bioAffinity Technologies, Inc. | 19.48M | 9.07% | 1,975,375 | 6.16M |
| 42 | MBAI | Check-Cap Ltd. | 12.10M | 1.22% | 10,655 | - |
| 43 | NOTV | Inotiv, Inc. | 9.83M | -5.39% | 36,407 | 514.03M |
| 44 | XWEL | XWELL, Inc. | 7.36M | -0.28% | 40,304 | 29.52M |
| 45 | QUCY | Mainz Biomed N.V. | 6.12M | -2.06% | 18,528 | 659.94K |
| 46 | NDRA | ENDRA Life Sciences Inc. | 5.25M | 20.00% | 90,165 | - |
| 47 | ADVB | Advanced Biomed Inc. | 4.32M | -6.78% | 98,786 | - |
| 48 | ISPC | iSpecimen Inc. | 1.53M | 0.64% | 623,297 | 3.35M |